Savvy Trades and Investments

[wadegarret]

GERN- their drug Rytelo is assumed a failure

now in my view. I mean what else would explain the stock going from $5.50 on FDA approval day to $2.80 today. While I understand that analysts were disappointed with 64% Q over Q growth of Rytelo for Q4 vs the 100% expected, I must ask why in the world would Institutions continue to load if GERNs drug were so bad ? Also can anyone know that GERNs drug will be a failure after only 6 months on the market ?